Shah Sujal — SEC Form 4 filings
SEC reporting owner CIK 1588861. 6 Form 4 filings on record with FilingPulse; latest filed 2026-06-11.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-01-26 to 2026-06-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 39.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CymaBay Therapeutics, Inc. (CBAY) | Chief Executive Officer, Director | 3 | — | — | 35 |
| Tvardi Therapeutics, Inc. (TVRD) | Director | 3 | — | — | 4 |
Form 4 filings — Shah Sujal
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-11 | 4 | Tvardi Therapeutics, Inc. (TVRD) | Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
| 2025-04-21 | 4 | Tvardi Therapeutics, Inc. (TVRD) | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2025-04-17 | 4 | Tvardi Therapeutics, Inc. (TVRD) | Grant/award (A): 10,394 (derivative) · Grant/award (A): 8,047 (derivative) | EDGAR |
| 2024-03-22 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Disposition to issuer (D): 310,420 · Disposition to issuer (D): 96,250 · Disposition to issuer (D): 88,351 (derivative) · Disposition to issuer (D): 39,375 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 47,916 (derivative) · +9 more | EDGAR |
| 2024-03-15 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Option exercise (M): 11,649 @ $10 · Option exercise (M): 14,625 @ $1.06 · Option exercise (M): 52,084 @ $1.72 · Option exercise (M): 18,899 @ $9.21 · Option exercise (M): 3,125 @ $11.69 · Option exercise (M): 14,372 @ $8.43 · +12 more | EDGAR |
| 2024-01-26 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Grant/award (A): 96,250 @ $0 · Grant/award (A): 357,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1588861 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →